Award details

Biological and regulatory properties of Vav-3 in B cell receptor signal transduction

ReferenceC17370
Principal Investigator / Supervisor Dr Martin Turner
Co-Investigators /
Co-Supervisors
Dr Elena Vigorito
Institution Babraham Institute
DepartmentBabraham Institute Department
Funding typeResearch
Value (£) 223,984
StatusCompleted
TypeResearch Grant
Start date 24/06/2002
End date 23/06/2005
Duration36 months

Abstract

Antigen recognition by lymphocytes triggers intracellular signalling pathways that are critical for the generation of a vigorous immune response. We have obtained preliminary evidence that Vav-3 is a new molecular component of this intracellular signalling pathway. Vav-3 is a guanine nucleotide exchange factor capable of promoting monomeric GTPases to their active state. We propose to test the hypothesis that Vav3 may activate multiple signalling pathways and serve as an integrator of such pathways. This project proposes to combine molecular, cellular and genetic approaches to define the mechanism by which Vav3 functions. This integrated approach will allow us to define the unique functions of Vav-3. A fuller understanding of the role that Vav-3 plays in antigen receptor signal transduction is anticipated to contribute to new strategies for immune manipulation.

Summary

unavailable
Committee Closed Committee - Biochemistry & Cell Biology (BCB)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file